# The Effect of rhDNase on Ventilation Inhomogeneity in Patients With Cystic Fibrosis

> **NCT00557089** · PHASE4 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 17 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** rhDNAse
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00557089
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2013-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557089, "The Effect of rhDNase on Ventilation Inhomogeneity in Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00557089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*